Key result
TAVI is associated with similar 1-year but higher in-hospital survival vs SAVR in low-risk patients.
Why the study?
Does transcatheter aortic valve implantation improve survival compared to surgical aortic valve replacement in patients with severe aortic valve stenosis at low surgical risk?
Population
20,549 patients with severe aortic valve stenosis at low surgical risk undergoing isolated TAVI or SAVR in…
Comparison
Transcatheter aortic valve implantation (TAVI) vs Surgical aortic valve replacement (SAVR)
Design
Cohort
Follow-up
1 year
Authors
Loading...
TAVI was associated with higher short-term but similar 1-year survival versus SAVR in low-risk patients; leaves open need for confirmatory randomized trials.
Observational (n=20,549)
Yes
Does transcatheter aortic valve implantation improve survival compared to surgical aortic valve replacement in patients with severe aortic valve stenosis at low surgical risk?
Absolute Event Rate: 90% vs 91.2%
p-value: p=0.158
In low-surgical-risk patients with severe aortic stenosis, TAVI is associated with higher short-term survival but similar 1-year survival compared to SAVR.
Bekeredjian et al. (2018) conducted an observational in Severe aortic valve stenosis at low surgical risk (n=20,549). Transcatheter aortic valve implantation (TAVI) vs. Surgical aortic valve replacement (SAVR) was evaluated on 1-year survival (p=0.158). In low-risk patients, TAVI demonstrated similar 1-year survival compared to SAVR (90.0% vs. 91.2%; P=0.158) and significantly higher in-hospital survival (98.5% vs. 97.3%; P=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: